Reversal of Obesity Cardiomyopathy

NCT01372397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2024-02-14

No results posted yet for this study

Summary

The overall purpose of this study is to determine if weight loss is beneficial for obese patients with diastolic heart failure.

Conditions

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Linda R Peterson, MD · Washington University School of Medicine

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-04-26
Completion
2012-04-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01372397 on ClinicalTrials.gov